MedCity News November 26, 2024
Marissa Plescia

In this episode, we’re joined by Dr. Piraye Yurttas Beim, founder and CEO of Celmatix, a women’s health biotech company. She discusses the funding the company recently received through the Sprint for Women’s Health program.

Welcome back to another episode of MedCity FemFwd, a podcast dedicated to discussing the breakthroughs and challenges in women’s health. In this episode, we’re joined...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Conferences / Podcast, Investments, Pharma / Biotech, Trends
AbbVie to write off $3.5B over failed schizophrenia drug
Drug Price Negotiation Requires Oversight To Protect Older Americans
5 questions facing emerging biotech in 2025
Lantheus (LNTH) Acquires Life Molecular Imaging for $750M
New Weight Loss Drugs May Fight Obesity-Related Cancer, Too

Share This Article